Stericycle, Inc. (NASDAQ:SRCL) to Post FY2024 Earnings of $2.35 Per Share, Barrington Research Forecasts

Stericycle, Inc. (NASDAQ:SRCL) – Analysts at Barrington Research upped their FY2024 earnings per share estimates for shares of Stericycle in a research report issued on Tuesday, April 30th. Barrington Research analyst K. Steinke now expects that the business services provider will earn $2.35 per share for the year, up from their previous forecast of $2.30. The consensus estimate for Stericycle’s current full-year earnings is $2.31 per share.

Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.03. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The firm had revenue of $664.90 million for the quarter, compared to analyst estimates of $676.42 million. During the same period in the prior year, the firm earned $0.49 earnings per share. The business’s quarterly revenue was down 2.8% compared to the same quarter last year.

Several other equities research analysts have also recently weighed in on the company. Truist Financial decreased their target price on Stericycle from $57.00 to $50.00 and set a “hold” rating for the company in a research note on Monday, April 29th. Stifel Nicolaus lifted their target price on shares of Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a report on Thursday, February 29th. Robert W. Baird dropped their price target on Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a research report on Friday, April 26th. StockNews.com cut Stericycle from a “buy” rating to a “hold” rating in a research report on Tuesday, April 2nd. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $69.00 target price on shares of Stericycle in a report on Thursday, March 7th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, Stericycle currently has a consensus rating of “Hold” and an average target price of $59.40.

Stericycle Price Performance

Stericycle stock opened at $46.18 on Friday. The stock has a market cap of $4.29 billion, a P/E ratio of -209.91, a price-to-earnings-growth ratio of 2.40 and a beta of 1.12. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.55. The company has a fifty day simple moving average of $50.99 and a 200-day simple moving average of $48.23. Stericycle has a 12-month low of $37.78 and a 12-month high of $57.06.

Institutional Trading of Stericycle

Several hedge funds have recently modified their holdings of the business. Capital Research Global Investors raised its position in Stericycle by 13.4% in the fourth quarter. Capital Research Global Investors now owns 5,987,937 shares of the business services provider’s stock worth $296,762,000 after acquiring an additional 705,586 shares in the last quarter. Sei Investments Co. increased its holdings in shares of Stericycle by 35.5% in the 4th quarter. Sei Investments Co. now owns 1,061,369 shares of the business services provider’s stock valued at $52,601,000 after purchasing an additional 277,896 shares in the last quarter. Ariel Investments LLC lifted its stake in shares of Stericycle by 5.7% in the third quarter. Ariel Investments LLC now owns 4,328,036 shares of the business services provider’s stock valued at $193,506,000 after purchasing an additional 233,612 shares during the period. Heartland Advisors Inc. boosted its holdings in Stericycle by 55.5% during the fourth quarter. Heartland Advisors Inc. now owns 583,545 shares of the business services provider’s stock worth $29,733,000 after buying an additional 208,256 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its position in Stericycle by 10.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,971,719 shares of the business services provider’s stock worth $97,720,000 after buying an additional 192,045 shares during the period. 98.82% of the stock is owned by institutional investors and hedge funds.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.